Real-World data reveals Tezepelumab's impact on severe asthma
NCT ID NCT06455462
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 23 times
Summary
This study looked back at the medical records of 352 adults with severe asthma who received tezepelumab in UK clinics. Researchers tracked asthma attacks, steroid use, and other outcomes for one year after starting treatment. The goal was to see how well the drug works in real-world settings, outside of controlled trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Birmingham, United Kingdom
-
Research Site
Liverpool, United Kingdom
-
Research Site
London, United Kingdom
-
Research Site
Newcastle, United Kingdom
-
Research Site
Plymouth, United Kingdom
-
Research Site
Southampton, United Kingdom
Conditions
Explore the condition pages connected to this study.